General form for registration of securities under the Securities Act of 1933

Stockholders??? Deficit (Tables)

v3.25.3
Stockholders’ Deficit (Tables)
12 Months Ended
Jul. 02, 2025
Sep. 30, 2024
Sonnet BioTherapeutics Holdings, Inc. [Member]    
Subsidiary or Equity Method Investee [Line Items]    
Schedule of Warrants Outstanding

As of June 30, 2025, the following equity-classified warrants and related terms were outstanding:

 

    Warrants Outstanding     Exercise Price     Expiration Date  
Common stock warrants August 2021     14,031     $ 2,094.4000       August 24, 2026  
Underwriter warrants August 2021     284     $ 2,618.0000       August 19, 2026  
Chanticleer warrants     6    

 

$144,144.00 - $224,224.00       April 30, 2027 - December 17, 2028  
Series C warrants     2,297     $ 7,860.1600       October 16, 2025  
Series 3 warrants     1,566     $ 717.0240       August 15, 2027  
Common stock warrants February 2023     31,563     $ 190.0800       February 10, 2028  
Underwriter warrants February 2023     1,933     $ 237.6000       February 8, 2028  
Common stock private placement warrants June 2023     28,409     $ 12.4000       June 21, 2029  
Placement agent warrants June 2023     852     $ 118.7824       December 30, 2026  
Common stock warrants October 2023     354,994     $ 9.6000       October 27, 2028  
Pre-funded warrants October 2023     99,687     $ 0.0008        
Underwriter warrants October 2023     10,664     $ 16.0000       October 24, 2028  
Placement agent warrants June 2024     14,142     $ 14.8800       June 19, 2029  
Common stock warrants June 2024     703,125     $ 12.4000       June 21, 2029  
Common stock warrants November 2024     2,222,222     $ 4.5000       November 7, 2029  
Common stock registered direct warrants December 2024     1,085,325     $ 2.1000       December 9, 2029  
Common stock PIPE warrants December 2024     673,000     $ 2.1000       December 9, 2029  
Pre-funded warrants December 2024     545,500     $ 0.0001        
Total     5,789,600                  

As of September 30, 2024, the following equity-classified warrants and related terms were outstanding:

 

    Warrants Outstanding     Exercise Price     Expiration Date
Common stock warrants August 2021     14,031     $ 2,094.40     August 24, 2026
Underwriter warrants August 2021     284     $ 2,618     August 19, 2026
Chanticleer warrants     6     $ 144,144.00 - $224,224.00     April 30, 2027 - December 17, 2028
Series C warrants     2,297     $ 7,860.16     October 16, 2025
Series 3 warrants     1,566     $ 717.024     August 15, 2027
Common stock warrants February 2023     33,982     $ 190.08     February 10, 2028
Underwriter warrants February 2023     1,933     $ 237.60     February 8, 2028
Common stock private placement warrants June 2023     28,409     $ 12.4000     June 21, 2029
Placement agent warrants June 2023     852     $ 118.7824     December 30, 2026
Common stock warrants October 2023     354,994     $ 9.6000     October 27, 2028
Pre-funded warrants October 2023     99,687     $ 0.0008    
Underwriter warrants October 2023     10,664     $ 16.0000     October 24, 2028
Placement agent warrants June 2024     14,142     $ 14.8800     June 19, 2029
Common stock warrants June 2024     703,125     $ 12.4000     June 21, 2029
Total     1,265,972